![](/img/cover-not-exists.png)
C21First Italian Multicentre Experience in using Ra-223 in patients with metastatic castration resistant prostate cancer (mCRPC)
Farnesi, A., Mazzarri, S., Galli, L., Boni, G., Cianci, C., Biasco, E., Sbrana, A., Monari, F., Dionisi, V., Graziani, T., Fanti, S., Massari, F., Ardizzoni, A., Borsatti, E., Bortolus, R., Gobitti, CVolume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw334.21
Date:
September, 2016
File:
PDF, 35 KB
english, 2016